Absent antibody production following COVID19 vaccination with mRNA in patients under immunosuppressive treatments

Patients undergoing immunosuppressive treatments have a higher need for protection against coronavirus disease (COVID19) that follows infection with the SARS-CoV-2 virus but their ability to respond sufficiently to COVID vaccines is uncertain. We retrospectively evaluated SARS-CoV-2 spike subunit 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Angelika, Jasinska, Joanna, Tomosel, Elena, Zielinski, Christoph C., Wiedermann, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier Ltd. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557974/
https://www.ncbi.nlm.nih.gov/pubmed/34785100
http://dx.doi.org/10.1016/j.vaccine.2021.10.068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557974/
https://www.ncbi.nlm.nih.gov/pubmed/34785100
http://dx.doi.org/10.1016/j.vaccine.2021.10.068

Ejemplares similares